Efficacy and safety of combined treatment with pembrolizumab in patients with locally advanced or metastatic esophageal squamous cell carcinoma in the real world

Pei Zhang(Sun Yat-sen University), Fang Liu(Henan Provincial People's Hospital), Emmanuel Gabriel(Mayo Clinic in Florida), Mingyue Zeng(Chinese PLA General Hospital), Ye Li(Hong Kong Polytechnic University), Jing Chen(Anhui University), Wei Yu(Chinese PLA General Hospital), Xiang Huang(Fujian Medical University), Zhipeng Ren(Chinese PLA General Hospital), Baolin Qu(Chinese PLA General Hospital), Xiaobin Hou(Chinese PLA General Hospital), Boning Cai(Chinese PLA General Hospital)
Annals of Translational Medicine
June 1, 2022
Cited by 8


Related Papers